MOAT ROSS (Group VP & Rilonacept GM) sold 12.4% of their position (1.70K shares) of KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC on the open market
Open‑market sale worth $79.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/13/2026ACC: 0001857177-26-000006
Officer· Group VP & Rilonacept GM
Since Apr 2021
-1.70K
Net shares
Net seller
$79.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.70K disposed
Non-Derivative Transactions1
Class A Ordinary Share
Direct
Shares
−1.70K
Price / share
$46.69
Trade value
$79.51K
% of position
12.4%
4/9/2026
13.73K→12.03K
Total
Net shares
−1.70K
Net value
-$79.51K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Ordinary Share Direct | 4/9/2026 | S · Sale | −1.70K | $46.69 | $79.51K | 12.4% | 13.73K | 12.03K |
| Total | −1.70K | -$79.51K | ||||||
Derivative Transactions0
No derivative transactions reported